
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
United States President Donald Trump has signed an executive order containing several directives to FDA and the Environmental Protection Agency (EPA), aiming to reduce regulatory barriers and restore a robust domestic manufacturing base for prescription …